Glioblastoma Multiforme Treatment Market Is Estimated to Grow at CAGR Of 8.1%, 2022-2029 | Latest Industry Coverage by Douglas Insights
11 janv. 2023 03h52 HE
|
Douglas Insights
Isle of Man, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Douglas Insights has added the Global Glioblastoma Multiforme treatment market research to its growing market reports. Douglas Insightsinsights tries...
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
24 sept. 2020 08h00 HE
|
CNS Pharmaceuticals, Inc.
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel...